drugset / Trial / NCT02203565

Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

NCT02203565

NaSingle-groupOpen-labelSupportive care

Summary

This pilot clinical trial studies Dakin's solution in preventing radiation dermatitis in patients with breast cancer undergoing radiation therapy. Radiation dermatitis is a skin condition in which the affected skin becomes painful, red, itchy, and blistered. Dakin's solution may help reduce dermatitis caused by radiation therapy.

Timeline

Start
2014-07
Primary completion
2016-07-07
Completion
2016-07-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Hypochlorite Unknown Topical